{"title": "Immunogenicity of SARS-CoV-2 Vaccine in Kidney Transplant Recipients: A Cross-Sectional Study in Korea", "author": "Song; Seung Hwan; Chung; Ku Yong; Jee; Yongho; Hae-Sun; Kim; Kina; Minn; Dohsik; Soo-Kyung", "url": "http://www.koreamed.org/SearchBasic.php?RID=2539195", "hostname": "koreamed.org", "description": "COVID-19; Kidney Transplantation; SARS-CoV-2; Vaccine", "sitename": "KoreaMed", "date": "2023-02-07", "cleaned_text": "1. Wei J, Stoesser N, Matthews PC, Ayoubkhani D, Studley R, Bell I, et al. Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom. Nat Microbiol. 2021; 6(9):1140-1149. PMID: [34290390](http://www.ncbi.nlm.nih.gov/pubmed/34290390) . M, Nohynek H, Kaslow DC, Kochhar S, et al. Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review. Lancet Glob Health. 2022; 10(3):e326-e328. PMID: [35180408](http://www.ncbi.nlm.nih.gov/pubmed/35180408) . 3. Lee SY, Chai LY, Lee SC, Lee MX, Muthiah MD, et al. Efficacy of COVID-19 vaccines in immunocompromised K, Mohan S, Cohen DJ, Husain SA. Clinically significant COVID-19 following SARS-CoV-2 vaccination in kidney transplant recipients. Am J Kidney Dis. 2021; 78(2):314-317. PMID: S, Reynolds JM, Kittipibul V, et al. COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature. Transplant Rev (Orlando). 2021; 35(1):100588. . JS, Abate M, Satapathy SK, Roth N, et al. An early experience on the effect of solid organ transplant status on hospitalized COVID-19 patients. Am J Transplant. 2021; 21(7):2522-2531. PMID: Wiwattanathum P. Benefits of inactivated vaccine and viral vector vaccine immunization on COVID-19 infection in kidney transplant recipients. Vaccines (Basel). 2022; 10(4):572. PMID: [35455322](http://www.ncbi.nlm.nih.gov/pubmed/35455322) . 8. Kang JM, Kim YJ, Huh K, Kim JM, Park WB, Ahn HJ, et al. COVID-19 among solid organ transplant recipients in Korea: surveillance data of the Korean Transplantation Society, January 2020 to March 2022. Korean J Transplant. 2022; 36(2):159-163. PMID: [35919200](http://www.ncbi.nlm.nih.gov/pubmed/35919200) . M, Nohynek H, Kaslow DC, Kochhar S, et al. Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review. Lancet Glob Zaidi SK, Campbell KM, Carethers JM, et al. Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited. Cancer Discov. 2021; van de Guchte A, Khan Z, Obla A, et al. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. N E, Klang E, Soffer S. Efficacy and safety of third dose of the COVID-19 vaccine among solid organ transplant recipients: a systemic review and meta-analysis. Vaccines (Basel). 2022; T, Graviss EA, Nguyen DT, Ibrahim H, et al. Risk factors associated with an impaired antibody response in kidney transplant recipients following 2 doses of the SARS-CoV-2 mRNA vaccine. et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in AB, Segev DL, et al. Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients. JAMA. 2021; 325(17):1784-1786. PMID: [33720292](http://www.ncbi.nlm.nih.gov/pubmed/33720292) . Ierullo M, Majchrzak-Kita B, Chaparro C, et al. Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients. N Engl J Med. 2021; PMID: Hamzaoui M, Lem\u00e9e V, Lamulle J, Laurent C, Etienne I, et al. Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients. Kidney Int. 2021; 100(6):1337-1340. PMID: [34619232](http://www.ncbi.nlm.nih.gov/pubmed/34619232) . 18. Kim N, Minn D, Park S, Roh EY, Yoon JH, Park H, et al. Positivity of SARS-CoV-2 antibodies among Korean healthy healthcare workers 1 and 2 weeks after second dose of Pfizer-BioNTech vaccination. J Korean Med Sci. 2021; 36(21):e158. PMID: [34060264](http://www.ncbi.nlm.nih.gov/pubmed/34060264) . 19. Park JS, Minn D, Hong S, Jeong S, Kim S, Lee CH, et al. Immunogenicity of COVID-19 vaccination in patients with end-stage renal disease undergoing maintenance hemodialysis: the efficacy of a mix-and-match strategy. J Korean Med 2022; Abra G, Argyropoulos C, Harper L, et al. Review of early immune response to SARS-CoV-2 vaccination among patients with CKD. Kidney Int Davidsen JR, Abazi R, et al. Determinants of antibody response to a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant Recipients: results from the prospective cohort study COVAC-Tx. Vaccines S, Cantarovich D, Hourmant M, et al. A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response. Kidney Int. 2021; 100(5):1132-1135. PMID: Tozzi R, Risi R, Masi D, et al. Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine. Diabetes Metab 2022; 38(1):e3465. Lee J, Huh KH, Joo DJ, Lee JG, Kim HR, et al. Matched versus mixed COVID-19 vaccinations in korean solid organ transplant recipients: an "}